Login to Your Account



Locteron Developer Biolex Liquidates; $35M in the Red

By Catherine Shaffer
Staff Writer

Wednesday, July 11, 2012
Biolex Therapeutics Inc., of Pittsboro, N.C., filed for bankruptcy liquidation, according to its partner OctoPlus N.V. The company aimed to make a better interferon for hepatitis C virus (HCV), and to that end burned through $185 million in venture capital since it was founded in 1997.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription